International cooperation to address
and counter the world drug problem
A/RES/74/178
of internationally recognized standards, such as the International Standards on Drug
Use Prevention, and the exchange of best practices, and to formulate effective drug
use prevention strategies and programmes in cooperation with the United Nations
Office on Drugs and Crime, the World Health Organization and other relevant United
Nations entities;
24. Encourages Member States, in their promotion and improvement of the
systematic collection of information and gathering of evidence, to gather scientific
data on any damage to health that may be caused by consuming drugs in vaporized
form, and to take appropriate steps to exchange best practices and formulate effective
drug use prevention strategies and programmes, with a particular focus on children
and youth;
25. Invites Member States to provide the United Nations Office on Drugs and
Crime with information on best practices and programmes recently implemented,
consistent with the three international drug control conventions, in order to assess
recent developments and current and future challenges;
26. Recognizes drug dependence as a complex, multifactorial health disorder
characterized by a chronic and relapsing nature, with social causes and consequences,
that can be prevented and treated through, inter alia, effective scientific evidencebased drug treatment, care and rehabilitation programmes, including community based programmes, and also recognizes the need to strengthen capacity for aftercare
for and the rehabilitation, recovery and social reintegra tion of individuals with
substance use disorders, including, as appropriate, through assistance for effective
reintegration into the labour market and other support services;
27. Encourages Member States to promote the prevention and treatment of
drug use disorders, using scientific evidence-based practices, such as those outlined
in the International Standards for the Treatment of Drug Use Disorders, that reflect
respect for human rights and dignity, including the right to enjoy the highest attainable
standard of physical and mental health and well-being, promoting, as appropriate,
within national and regional contexts, non-stigmatizing attitudes in the development
and implementation of scientific evidence-based policies;
28. Also encourages Member States to promote the inclusion in national drug
policies, in accordance with national legislation and as appropriate, of elements for
the prevention and treatment of drug overdose, in particular opioid overdose,
including the use of opioid receptor antagonists, such as naloxone, to reduce drugrelated mortality;
29. Invites Member States to promote cooperation with and technical
assistance to the States most affected by the world drug problem in developing and
implementing comprehensive and integrated policies to address, where appropriate,
the impact of illicit drug trafficking on increasing drug use in such States, including
by reinforcing national programmes aimed at prevention, early intervention,
treatment, care, rehabilitation and social reintegration;
30. Encourages the United Nations Office on Drugs and Crime and the
International Narcotics Control Board to continue to strengthen cooperation with the
World Health Organization and other competent United Nations entities, within their
respective mandates, as part of a comprehensive, integrated and balanced approach to
strengthening health and social welfare measures in addressing the world drug
problem, including through effective prevention, early intervention, treatment, care,
recovery, rehabilitation and social reintegration, in cooperation, as appropriate, with
civil society and the scientific community, and to keep the Commission on Narcotic
Drugs appropriately updated;
19-22335
9/23
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents